Found: 109
Select item for more details and to access through your institution.
The potent psychomotor, rewarding and reinforcing properties of 3-fluoromethamphetamine in rodents.
- Published in:
- 2020
- By:
- Publication type:
- journal article
The new designer drug buphedrone produces rewarding properties via dopamine D1 receptor activation.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Impairment of opiate-mediated behaviors by the selective TRPV1 antagonist SB366791.
- Published in:
- 2017
- By:
- Publication type:
- journal article
The new stimulant designer compound pentedrone exhibits rewarding properties and affects dopaminergic activity.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Protective effects of heme oxygenase-1 against MPP(+)-induced cytotoxicity in PC-12 cells.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Mepirapim, a Novel Synthetic Cannabinoid, Induces Addiction-Related Behaviors through Neurochemical Maladaptation in the Brain of Rodents.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 6, p. 710, doi. 10.3390/ph15060710
- By:
- Publication type:
- Article
Frequency of CYP2C9 alleles in Koreans and their effects on losartan pharmacokinetics.
- Published in:
- Acta Pharmacologica Sinica, 2011, v. 32, n. 10, p. 1303, doi. 10.1038/aps.2011.100
- By:
- Publication type:
- Article
Mepirapim, a novel synthetic cannabinoid, induces Parkinson's disease-related behaviors by causing maladaptation of the dopamine system in the brain.
- Published in:
- Archives of Toxicology, 2023, v. 97, n. 2, p. 581, doi. 10.1007/s00204-022-03414-y
- By:
- Publication type:
- Article
N-Methyl- d-aspartate Receptor Antagonists Enhance the Head-twitch Response, a 5-Hydroxytryptamine<sub>2</sub> Receptor-mediated Behaviour, in Reserpine-treated Mice.
- Published in:
- Journal of Pharmacy & Pharmacology, 2000, v. 52, n. 6, p. 717, doi. 10.1211/0022357001774390
- By:
- Publication type:
- Article
A sensitive and accurate quantitative method to determine N-arachidonoyldopamine and N-oleoyldopamine in the mouse striatum using column-switching LC-MS-MS: use of a surrogate matrix to quantify endogenous compounds.
- Published in:
- Analytical & Bioanalytical Chemistry, 2014, v. 406, n. 18, p. 4491, doi. 10.1007/s00216-014-7816-6
- By:
- Publication type:
- Article
Development of a simultaneous analytical method for selected anorectics, methamphetamine, MDMA, and their metabolites in hair using LC-MS/MS to prove anorectics abuse.
- Published in:
- Analytical & Bioanalytical Chemistry, 2012, v. 403, n. 5, p. 1385, doi. 10.1007/s00216-012-5950-6
- By:
- Publication type:
- Article
Genetic overexpressing of GPx-1 attenuates cocaine-induced renal toxicity via induction of anti-apoptotic factors.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2016, v. 43, n. 4, p. 428, doi. 10.1111/1440-1681.12557
- By:
- Publication type:
- Article
Inhibition of protein kinase ( PK) C δ attenuates methamphetamine-induced dopaminergic toxicity via upregulation of phosphorylation of tyrosine hydroxylase at Ser<sup>40</sup> by modulation of protein phosphatase 2 A and PKA.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2015, v. 42, n. 2, p. 192, doi. 10.1111/1440-1681.12341
- By:
- Publication type:
- Article
Exposure to far-infrared ray attenuates methamphetamine-induced impairment in recognition memory through inhibition of protein kinase C δ inmale mice: Comparisonwith the antipsychotic clozapine.
- Published in:
- Journal of Neuroscience Research, 2018, v. 96, n. 7, p. 1294, doi. 10.1002/jnr.24228
- By:
- Publication type:
- Article
PBPK modeling to predict the pharmacokinetics of pantoprazole in different CYP2C19 genotypes.
- Published in:
- Archives of Pharmacal Research, 2024, v. 47, n. 1, p. 82, doi. 10.1007/s12272-023-01478-7
- By:
- Publication type:
- Article
PBPK modeling to predict the pharmacokinetics of venlafaxine and its active metabolite in different CYP2D6 genotypes and drug–drug interactions with clarithromycin and paroxetine.
- Published in:
- Archives of Pharmacal Research, 2024, v. 47, n. 5, p. 481, doi. 10.1007/s12272-024-01495-0
- By:
- Publication type:
- Article
The novel psychoactive substance 25E-NBOMe induces reward-related behaviors via dopamine D1 receptor signaling in male rodents.
- Published in:
- Archives of Pharmacal Research, 2024, v. 47, n. 4, p. 360, doi. 10.1007/s12272-024-01491-4
- By:
- Publication type:
- Article
Physiologically based pharmacokinetic (PBPK) modeling of pitavastatin in relation to SLCO1B1 genetic polymorphism.
- Published in:
- Archives of Pharmacal Research, 2024, v. 47, n. 2, p. 95, doi. 10.1007/s12272-023-01476-9
- By:
- Publication type:
- Article
Physiologically based pharmacokinetic (PBPK) modeling to predict the pharmacokinetics of irbesartan in different CYP2C9 genotypes.
- Published in:
- Archives of Pharmacal Research, 2023, v. 46, n. 11/12, p. 939, doi. 10.1007/s12272-023-01472-z
- By:
- Publication type:
- Article
Effects of CYP2D6 and CYP2C19 genetic polymorphisms and cigarette smoking on the pharmacokinetics of tolperisone.
- Published in:
- Archives of Pharmacal Research, 2023, v. 46, n. 8, p. 713, doi. 10.1007/s12272-023-01462-1
- By:
- Publication type:
- Article
Effects of CYP2C9 and CYP2C19 genetic polymorphisms on the pharmacokinetics and pharmacodynamics of gliclazide in healthy subjects.
- Published in:
- Archives of Pharmacal Research, 2023, v. 46, n. 5, p. 438, doi. 10.1007/s12272-023-01448-z
- By:
- Publication type:
- Article
Effects of CYP2D6*10 allele on the pharmacokinetics of tolperisone.
- Published in:
- Archives of Pharmacal Research, 2023, v. 46, n. 1, p. 59, doi. 10.1007/s12272-022-01422-1
- By:
- Publication type:
- Article
Effects of CYP2C19 genetic polymorphism on the pharmacokinetics of tolperisone in healthy subjects.
- Published in:
- Archives of Pharmacal Research, 2023, v. 46, n. 2, p. 111, doi. 10.1007/s12272-022-01423-0
- By:
- Publication type:
- Article
Physiologically based pharmacokinetic (PBPK) modeling of flurbiprofen in different CYP2C9 genotypes.
- Published in:
- Archives of Pharmacal Research, 2022, v. 45, n. 8, p. 584, doi. 10.1007/s12272-022-01403-4
- By:
- Publication type:
- Article
Physiologically based pharmacokinetic modeling of candesartan related to CYP2C9 genetic polymorphism in adult and pediatric patients.
- Published in:
- Archives of Pharmacal Research, 2021, v. 44, n. 12, p. 1109, doi. 10.1007/s12272-021-01363-1
- By:
- Publication type:
- Article
Effects of CYP2C9*3 and *13 alleles on the pharmacokinetics and pharmacodynamics of glipizide in healthy Korean subjects.
- Published in:
- Archives of Pharmacal Research, 2022, v. 45, n. 2, p. 114, doi. 10.1007/s12272-021-01366-y
- By:
- Publication type:
- Article
Physiologically based pharmacokinetic modelling to predict the pharmacokinetics of metoprolol in different CYP2D6 genotypes.
- Published in:
- Archives of Pharmacal Research, 2022, v. 45, n. 6, p. 433, doi. 10.1007/s12272-022-01394-2
- By:
- Publication type:
- Article
Physiologically based pharmacokinetic (PBPK) modeling of piroxicam with regard to CYP2C9 genetic polymorphism.
- Published in:
- Archives of Pharmacal Research, 2022, v. 45, n. 5, p. 352, doi. 10.1007/s12272-022-01388-0
- By:
- Publication type:
- Article
Physiologically based pharmacokinetic (PBPK) modeling of meloxicam in different CYP2C9 genotypes.
- Published in:
- Archives of Pharmacal Research, 2021, v. 44, n. 12, p. 1076, doi. 10.1007/s12272-021-01361-3
- By:
- Publication type:
- Article
Physiologically based pharmacokinetic (PBPK) modelling of tamsulosin related to CYP2D6*10 allele.
- Published in:
- Archives of Pharmacal Research, 2021, v. 44, n. 11, p. 1037, doi. 10.1007/s12272-021-01357-z
- By:
- Publication type:
- Article
Physiologically based pharmacokinetic (PBPK) modeling for prediction of celecoxib pharmacokinetics according to CYP2C9 genetic polymorphism.
- Published in:
- Archives of Pharmacal Research, 2021, v. 44, n. 7, p. 713, doi. 10.1007/s12272-021-01346-2
- By:
- Publication type:
- Article
Methamphetamine-induced dopaminergic neurotoxicity as a model of Parkinson's disease.
- Published in:
- Archives of Pharmacal Research, 2021, v. 44, n. 7, p. 668, doi. 10.1007/s12272-021-01341-7
- By:
- Publication type:
- Article
Correction to: Relationship between plasma exposure of zolpidem and CYP2D6 genotype in healthy Korean subjects.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
ABCB1 c.2677G>T/c.3435C>T diplotype increases the early-phase oral absorption of losartan.
- Published in:
- Archives of Pharmacal Research, 2020, v. 43, n. 11, p. 1187, doi. 10.1007/s12272-020-01294-3
- By:
- Publication type:
- Article
Effects of paroxetine on the pharmacokinetics of atomoxetine and its metabolites in different CYP2D6 genotypes.
- Published in:
- Archives of Pharmacal Research, 2020, v. 43, n. 12, p. 1356, doi. 10.1007/s12272-020-01300-8
- By:
- Publication type:
- Article
Effects of CYP2D6 genetic polymorphism on the pharmacokinetics of metoclopramide.
- Published in:
- Archives of Pharmacal Research, 2020, v. 43, n. 11, p. 1207, doi. 10.1007/s12272-020-01293-4
- By:
- Publication type:
- Article
Flavonoids as therapeutic candidates for emotional disorders such as anxiety and depression.
- Published in:
- Archives of Pharmacal Research, 2020, v. 43, n. 11, p. 1128, doi. 10.1007/s12272-020-01292-5
- By:
- Publication type:
- Article
Relationship between plasma exposure of zolpidem and CYP2D6 genotype in healthy Korean subjects.
- Published in:
- Archives of Pharmacal Research, 2020, v. 43, n. 9, p. 976, doi. 10.1007/s12272-020-01250-1
- By:
- Publication type:
- Article
Protective effects of 6,7,4′-trihydroxyisoflavone, a major metabolite of daidzein, on 6-hydroxydopamine-induced neuronal cell death in SH-SY5Y human neuroblastoma cells.
- Published in:
- Archives of Pharmacal Research, 2019, v. 42, n. 12, p. 1081, doi. 10.1007/s12272-019-01191-4
- By:
- Publication type:
- Article
Effects of steady-state clarithromycin on the pharmacokinetics of zolpidem in healthy subjects.
- Published in:
- Archives of Pharmacal Research, 2019, v. 42, n. 12, p. 1101, doi. 10.1007/s12272-019-01201-5
- By:
- Publication type:
- Article
Isoorientin improves scopolamine-induced cognitive impairments by restoring the cholinergic system, antioxidant defense, and p-CREB/BDNF signaling in the hippocampus and frontal cortex.
- Published in:
- Archives of Pharmacal Research, 2019, v. 42, n. 8, p. 722, doi. 10.1007/s12272-019-01172-7
- By:
- Publication type:
- Article
Influence of CYP2D6 genetic polymorphism on pharmacokinetics of active moiety of tolterodine.
- Published in:
- Archives of Pharmacal Research, 2019, v. 42, n. 2, p. 182, doi. 10.1007/s12272-018-1099-y
- By:
- Publication type:
- Article
CYP2D6 allele frequencies in Korean population, comparison with East Asian, Caucasian and African populations, and the comparison of metabolic activity of CYP2D6 genotypes.
- Published in:
- Archives of Pharmacal Research, 2018, v. 41, n. 9, p. 921, doi. 10.1007/s12272-018-1075-6
- By:
- Publication type:
- Article
The influences of CYP2C9*1/*3 genotype on the pharmacokinetics of zolpidem.
- Published in:
- Archives of Pharmacal Research, 2018, v. 41, n. 9, p. 931, doi. 10.1007/s12272-018-1070-y
- By:
- Publication type:
- Article
Effects of genetic polymorphisms of CYP2C19 on the pharmacokinetics of zolpidem.
- Published in:
- Archives of Pharmacal Research, 2018, v. 41, n. 8, p. 861, doi. 10.1007/s12272-018-1065-8
- By:
- Publication type:
- Article
Effects of diltiazem, a moderate inhibitor of CYP3A4, on the pharmacokinetics of tamsulosin in different CYP2D6 genotypes.
- Published in:
- Archives of Pharmacal Research, 2018, v. 41, n. 5, p. 564, doi. 10.1007/s12272-018-1030-6
- By:
- Publication type:
- Article
Effect of the <italic>CYP2D6*10</italic> allele on the pharmacokinetics of clomiphene and its active metabolites.
- Published in:
- Archives of Pharmacal Research, 2018, v. 41, n. 3, p. 347, doi. 10.1007/s12272-018-1005-7
- By:
- Publication type:
- Article
Inhibition of salivary secretion by tolterodine transdermal patch.
- Published in:
- Archives of Pharmacal Research, 2017, v. 40, n. 12, p. 1455, doi. 10.1007/s12272-017-0988-9
- By:
- Publication type:
- Article
Simultaneous determination of tolterodine and its two metabolites, 5-hydroxymethyltolterodine and N-dealkyltolterodine in human plasma using LC-MS/MS and its application to a pharmacokinetic study.
- Published in:
- Archives of Pharmacal Research, 2017, v. 40, n. 11, p. 1287, doi. 10.1007/s12272-017-0981-3
- By:
- Publication type:
- Article
Liquiritigenin ameliorates memory and cognitive impairment through cholinergic and BDNF pathways in the mouse hippocampus.
- Published in:
- Archives of Pharmacal Research, 2017, v. 40, n. 10, p. 1209, doi. 10.1007/s12272-017-0954-6
- By:
- Publication type:
- Article